Stay updated on Depemokimab in Severe Asthma Clinical Trial

Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new publication citation has been added: Heffler E et al., Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis. Front Allergy, 2026.
    Difference
    0.0%
    Check dated 2026-03-29T00:17:03.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added to the page. The previous revision entry, v3.4.3, has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T17:11:14.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new publication entry for Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2 (Adv Ther, 2026; doi: 10.1007/s12325-025-03457-4) and removed the 2025 ahead-of-print reference. The study record version has been updated to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T09:28:25.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added in place of v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T16:59:19.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-06T11:01:18.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now shows a glossary and the last QC-update label has been changed to 'Last Update Submitted that Met QC Criteria'. Revision metadata has been updated to 'Revision: v3.4.0' (replacing the previous v3.3.4) and 'No FEAR Act Data' capitalization adjusted.
    Difference
    0.1%
    Check dated 2026-01-29T03:12:02.000Z thumbnail image

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.